CPC A61K 39/29 (2013.01) [A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61M 37/0015 (2013.01); A61K 9/0021 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/003 (2013.01); A61M 2202/30 (2013.01)] | 13 Claims |
1. A microneedle array for use in the intradermal application for hepatitis vaccination, wherein the microneedle array consists of HBsAg, and 1 to 95% by weight of polyvinylpyrrolidone and
trehalose 0.1 to 50% by weight as an auxiliary
polysorbate 0.01 to 10% by weight as an auxiliary and
glycerol 0.1 to 10% by weight as an auxiliary.
|